HIV: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 200+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Terminated

  Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 2

  NCT06006143· Yale University· Updated 6 Nov 2026

  “recruitment challenges”Registry text, quoted unchanged. Source

• Terminated

  A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion or Subcutaneous (SC) Injection of Budigalimab and/or ABBV-382

  NCT06032546· AbbVie· Updated 6 Nov 2026

  “Company Decision”Registry text, quoted unchanged. Source

• Terminated

  IBIS Megastudy- Pilot

  NCT06785103· University of California, San Francisco· Updated 19 Oct 2026

  “On 5/1/25, the US NIH issued Notice: NOT-OD-25-104, which prohibited foreign subawards from being nested under a parent grant. Our pilot trial was scheduled for renewal on 8/1/25, and the NOA was delayed. Without funding, we had to halt the trial.”Registry text, quoted unchanged. Source

• Terminated

  A Study to Assess the Safety and Pharmacokinetics of a Human Monoclonal Antibody (VH4527079) in Healthy Adults and Persons With HIV

  NCT06652958· ViiV Healthcare· Updated 15 Oct 2026

  “Terminated for business reasons”Registry text, quoted unchanged. Source

• Terminated

  Validation of Self Testing Using the INSTI Multiplex HIV1/2 Syphilis Antibody Test

  NCT06953024· Nova Scotia Health Authority· Updated 1 Oct 2026

  “The study was terminated prematurely because the futility threshold was met.”Registry text, quoted unchanged. Source

• Suspended

  The DART DELIVER-02 Study

  NCT07217379· University of North Carolina, Chapel Hill· Updated 22 Sept 2026

  “Study was put on pause on July 29, 2026, due to a Grade 5 Serious adverse event”Registry text, quoted unchanged. Source

• Withdrawn

  ComBaCaL HIV Prevention TwiCs

  NCT07581600· University Hospital, Basel, Switzerland· Updated 16 Sept 2026

  “The study was withdrawn before initiation. Reasons: no ethics approval obtained and anticipated roll-out of lenacapavir”Registry text, quoted unchanged. Source

• Terminated

  Prospective Clinical Performance Evaluation of the In-Vitro Diagnostics Medical Device MaGIA IBC for the CombIned screENing of HIV, Hepatitis B and Hepatitis C

  NCT06082336· MagIA Diagnostics· Updated 11 Sept 2026

  “Liquidation of MagIA Diagnostics”Registry text, quoted unchanged. Source

• Withdrawn

  A Pilot Study of an Online HIV Stigma Training for Nursing Students in Iran

  NCT06509113· University of California, San Francisco· Updated 8 Sept 2026

  “UCSF could not find a way to pay our partner institute (subcontractor) in Iran due to sanctions, and so decided to stop the study.”Registry text, quoted unchanged. Source

• Suspended

  Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1

  NCT06071767· National Institute of Allergy and Infectious Diseases (NIAID)· Updated 2 Sept 2026

  “Temporarily Closed (Paused) to Accrual and Study Agents/Products”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• NOTRE: Optimizing Long-Acting Pre-Exposure Prophylaxis and Medications for Opioid Use Disorder Interventions in Carceral Settings

  NCT06854029· Duke University· Source

• Olfactory Function and Model-Based Behavior in People Living With HIV and SUD

  NCT07637669· National Institute on Drug Abuse (NIDA)· Source

• Prescribe to Prevent HIV: A Hybrid Trial Helping Addiction Clinics Prevent HIV & Infections Through Safer Drug Use Support

  NCT07073924· University of Pittsburgh· Source

• HIV/STI/HCV Testing and Overdose Prevention Among Survivors of Sex Trafficking

  NCT07264582· Columbia University· Source

• Effect of Omega-3 Supplementation on Pregnant Outcomes and Inflammation Markers of Women Infected With HIV Using Antiretroviral Therapy

  NCT06971445· Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes· Source

• Smoking Cessation Program for Lao People With HIV

  NCT07014605· University of Oklahoma· Source

• Trial Phase: Syndemic Adapted Medly Uganda

  NCT07525271· Yale University· Source

• Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus)

  NCT06497504· GlaxoSmithKline· Source

• A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion or Subcutaneous (SC) Injection of Budigalimab and/or ABBV-382

  NCT06032546· AbbVie· Source

• Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer

  NCT02108028· National Cancer Institute (NCI)· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 21
• Organoids 6
• Mendelian Randomization Analysis 7
• CRISPR-Cas Systems 27
• Gene Expression Profiling 62
• Sequence Analysis, RNA 5
• Whole Genome Sequencing 15
• Exome Sequencing 3
• Proteomics 37
• Metabolomics 32
• Mass Spectrometry 16
• Flow Cytometry 45
• Immunohistochemistry 15
• Xenograft Model Antitumor Assays 3
• Positron-Emission Tomography 4
• Magnetic Resonance Imaging 77
• Machine Learning 71
• Deep Learning 20
• Cohort Studies 424
• Genome-Wide Association Study 20

• Cytomegalovirus Immune Responses and Cognitive Impairment in People With Human Immunodeficiency Virus.

  J Infect Dis, Sept 2026

• Diagnostic accuracy of the VISITECT CD4 lateral-flow assay for screening advanced HIV disease: A systematic review and meta-analysis.

  Int J Infect Dis, Sept 2026

• Performance Evaluation of the VISITECT CD4 Lateral Flow Point-Of-Care Assay for Identifying Advanced HIV Disease.

  J Clin Lab Anal, Aug 2026

• Apparent cooperativity between human CMV virions introduces errors in conventional methods of calculating multiplicity of infection.

  Elife, Aug 2026

• Selection of effective LRAs using a newly designed in vitro HIV latency reactivation protocol: toward future application in HIV samples.

  Microbiol Spectr, Aug 2026

• Immunosenescence and immune dysfunction in treated and untreated HIV-infected individuals.

  Indian J Med Res, Aug 2026

• Epigenetic CD4+ T-Cell Quantification from Dried Blood Spots Using a Real-Time Quantitative PCR-Based Assay.

  J Mol Diagn, Jul 2026

• A Distinct Immune Signature Characterizes Cirrhosis in Ethiopian Individuals With Chronic HBV Infection.

  Aliment Pharmacol Ther, Jul 2026

• Predictive value of peripheral lymphocyte subsets in relation to opportunistic infections in people living with HIV/AIDS.

  BMC Infect Dis, Jun 2026

• Expansion of NKG2A+CD8+ T cells with regulatory signatures distinguish individuals living with HIV-2 from those with HIV-1.

  Med, May 2026

See which targets of this disease your abstract mentions, and go to the people working on them.